Donor-recipient matching: Myths and realities

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 61, Issue 2, Pages (August 2014)
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
MELD: the holy grail of organ allocation?
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies  Gennaro D'Amico, Guadalupe Garcia-Tsao, Luigi.
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Volume 59, Issue 6, Pages (December 2013)
Liver transplantation using Donation after Cardiac Death donors
Volume 68, Issue 5, Pages (May 2018)
Volume 61, Issue 6, Pages (December 2014)
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Immigration and viral hepatitis
Volume 66, Issue 1, Pages 1-4 (January 2017)
Living donor liver transplantation: is the hype over?
What lessons have we learned in pediatric liver transplantation?
Reply to: “DCD consensus and futility in liver transplantation”
The place of downstaging for hepatocellular carcinoma
Volume 58, Issue 3, Pages (March 2013)
Mauro Bernardi, Stefano Gitto, Maurizio Biselli  Journal of Hepatology 
Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure”  Rakhi Maiwall,
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Jay A. Graham, James V. Guarrera  Journal of Hepatology 
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Who should get a liver graft?
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Age and liver transplantation
The heart in liver transplantation
The changing role of beta-blocker therapy in patients with cirrhosis
EASL Clinical Practice Guidelines on hepatitis E virus infection
Volume 57, Issue 5, Pages (November 2012)
Volume 50, Issue 4, Pages (April 2009)
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Portal vein thrombosis, cirrhosis, and liver transplantation
Immigration and viral hepatitis
Evolution of liver transplantation for hepatocellular carcinoma
The potential of induced pluripotent stem cell derived hepatocytes
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
Volume 63, Issue 1, Pages (July 2015)
The use of hemospray in portal hypertensive bleeding; a case series
Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice  Paolo Angeli, Pere Gines 
Volume 66, Issue 4, Pages (April 2017)
HCV animal models and liver disease
New trials and results in systemic treatment of HCC
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
Chimeric mouse model of hepatitis B virus infection
Comment on the article “Age and liver transplantation”
Discussion The Journal of Thoracic and Cardiovascular Surgery
MELD: the holy grail of organ allocation?
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Outcomes in liver transplantation: Does sex matter?
Volume 70, Issue 5, Pages (May 2019)
Presentation transcript:

Donor-recipient matching: Myths and realities Javier Briceño, Ruben Ciria, Manuel de la Mata  Journal of Hepatology  Volume 58, Issue 4, Pages 811-820 (April 2013) DOI: 10.1016/j.jhep.2012.10.020 Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Current composite formulations of donor-risk-based systems (left), patient-risk-based systems (right) and combined donor-recipient-based systems (middle) for donor-recipient matching available in literature. COD (cause of death), CVA (cardiovascular accident), DCDD (donation after circulatory determination of death) and PVT (portal vein thrombosis). Journal of Hepatology 2013 58, 811-820DOI: (10.1016/j.jhep.2012.10.020) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Chronology of donor-recipient matching in liver transplantation. As observed, prior to 1995, D-R matching was unclear. In the last 15–20years, several changes have led to a change in the mentality of liver transplant teams, leading to more complex methods of allocation in order to obtain the best survival and the lowest rate of deaths on waiting list. Journal of Hepatology 2013 58, 811-820DOI: (10.1016/j.jhep.2012.10.020) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2013 58, 811-820DOI: (10. 1016/j. jhep. 2012. 10 Copyright © 2012 European Association for the Study of the Liver Terms and Conditions